STRATEGIES FOR PREVENTION OF INFECTION AFTER CARDIAC TRANSPLANTATION

被引:23
作者
KEATING, MR [1 ]
WILHELM, MP [1 ]
WALKER, RC [1 ]
机构
[1] MAYO CLIN & MAYO FDN, DIV INFECT DIS & INTERNAL MED, ROCHESTER, MN 55905 USA
关键词
D O I
10.1016/S0025-6196(12)60725-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infection remains a major cause of morbidity and mortality after cardiac transplantation. Most infections occur during the first few months after transplantation. Although late infection does occur, the risk of infection during maintenance immunosuppression is low in the absence of recurrent rejection that necessitates augmentation of suppression of the immune response. Before cardiac transplantation, the risk factors for infectious disease in potential candidates should be assessed. A detailed history of past infections should be elicited, and patients should be screened for the presence of active indolent infection. In addition, potential donors must be thoroughly assessed for organ-transmittable infection. Many common infections that may occur after cardiac transplantation can be prevented with the use of appropriate prophylactic regimens directed toward cytomegalovirus, Toxoplasma gondii, Pneumocystis carinii, and herpes simplex virus. Periodic surveillance serologic tests and cultures after cardiac transplantation facilitate early diagnosis and prompt institution of appropriate therapy.
引用
收藏
页码:676 / 684
页数:9
相关论文
共 65 条
[31]  
KRIETT JM, 1990, J HEART TRANSPLANT, V9, P323
[32]   USE OF POTENTIALLY INFECTED DONOR HEARTS FOR CARDIAC TRANSPLANTATION [J].
LAMMERMEIER, DE ;
SWEENEY, MS ;
HAUPT, HE ;
RADOVANCEVIC, B ;
DUNCAN, JM ;
FRAZIER, OH .
ANNALS OF THORACIC SURGERY, 1990, 50 (02) :222-225
[33]  
LASKE A, 1991, TRANSPLANT P, V23, P1170
[34]  
LINDER J, 1988, J HEART TRANSPLANT, V7, P390
[35]   PRIMARY AND REACTIVATED TOXOPLASMA INFECTION IN PATIENTS WITH CARDIAC TRANSPLANTS - CLINICAL SPECTRUM AND PROBLEMS IN DIAGNOSIS IN A DEFINED POPULATION [J].
LUFT, BJ ;
NAOT, Y ;
ARAUJO, FG ;
STINSON, EB ;
REMINGTON, JS .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (01) :27-31
[36]  
McCabe R. E., 1990, Principles and practice of infectious diseases., P2090
[37]  
MERIGAN T, 1991, Journal of Heart and Lung Transplantation, V10, P175
[38]   CYTOMEGALOVIRUS SERONEGATIVE HEART-TRANSPLANT RECIPIENTS - PROPHYLACTIC USE OF ANTI-CMV IMMUNOGLOBULIN [J].
METSELAAR, HJ ;
BALK, AHMM ;
MOCHTAR, B ;
ROTHBARTH, PH ;
WEIMAR, W .
CHEST, 1990, 97 (02) :396-399
[39]  
MEUNIER F, 1987, REV INFECT DIS, V9, P408
[40]  
MILLIKEN ST, 1990, REV INFECT DIS, V12, pS374